Integra Lifesciences Holdings (IART) Deferred Taxes (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Deferred Taxes of -$4.3 million for Q2 2026, down 426.77% sequentially from $1.3 million in Q1 2026, and up 90.33% YoY from -$2.3 million in Q2 2025.
Integra Lifesciences Holdings (IART) Deferred Taxes (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Deferred Taxes for 18 years, with the latest figure at -$4.3 million in Q2 2026.
- Quarterly Deferred Taxes rose 90.33% year-over-year to -$4.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$22.6 million (up 63.94% YoY) and the FY2025 annual result came in at -$66.3 million, down 219.64% from the prior year.
- Deferred Taxes retreated to -$4.3 million in Q2 2026 per IART's latest filing, from $1.3 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $4.0 million in Q2 2022 and troughed at -$44.8 million in Q2 2025.
- A 5-year average of -$5.9 million and a median of -$3.6 million in 2024 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2022 and 2025: Deferred Taxes surged 387.2% in 2022, then tumbled 2331.18% in 2025.
- Over 5 years, Deferred Taxes stood at -$6.0 million in 2022, then sank by 146.48% to -$14.8 million in 2023, then soared by 52.94% to -$7.0 million in 2024, then sank by 56.67% to -$10.9 million in 2025, then jumped by 60.42% to -$4.3 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$4.3 million, $1.3 million, and -$10.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 107.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 17.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -181.30 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -300,000.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 235.96 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 600,000.00 |
| 10 | Integra Lifesciences Holdings | 1.30 Bn | 1.02 Bn | 219.74 Mn | -4.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.33 Mn |
| Mar 31, 2026 | 1.33 Mn |
| Dec 31, 2025 | -10.95 Mn |
| Sep 30, 2025 | -8.65 Mn |
| Jun 30, 2025 | -44.83 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | -6.99 Mn |
| Sep 30, 2024 | -9.04 Mn |
| Jun 30, 2024 | -1.84 Mn |
| Mar 31, 2024 | -2.86 Mn |
| Dec 31, 2023 | -14.85 Mn |
| Sep 30, 2023 | 1.24 Mn |
| Jun 30, 2023 | -227,000.00 |
| Mar 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | -6.02 Mn |
| Sep 30, 2022 | -6.10 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 10.74 Mn |
| Sep 30, 2021 | -8.59 Mn |